15 years of clinical experience with bupropion HCl: from bupropion to bupropion SR to bupropion XL - Wikidata - awgldk - TriplyDB

15 years of clinical experience with bupropion HCl: from bupropion to bupropion SR to bupropion XL

15 years of clinical experience with bupropion HCl: from bupropion to bupropion SR to bupropion XL

http://www.wikidata.org/entity/Q24530904

about

Treatment of adults with attention-deficit/hyperactivity disorder Treatment of adults with attention-deficit/hyperactivity disorder Bupropion: a systematic review and meta-analysis of effectiveness as an antidepressant Update on medicines for smoking cessation A brief history of the development of antidepressant drugs: from monoamines to glutamate The noradrenergic action in antidepressant treatments: pharmacological and clinical aspects Delayed onset urticaria in depressive patients with bupropion prescription: a nationwide population-based study Comparison of adjunctive use of aripiprazole with bupropion or selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors: analysis of patients beginning adjunctive treatment in a 52-week, open-label study.The efficacy and safety of bupropion sustained-release formulation for the treatment of major depressive disorder: a multi-center, randomized, double-blind, placebo-controlled study in Asian patients Pharmacological means of reducing human drug dependence: a selective and narrative review of the clinical literature.Pathways linking socioeconomic status to obesity through depression and lifestyle factors among young US adults.Chronic imipramine but not bupropion increases arachidonic acid signaling in rat brain: is this related to 'switching' in bipolar disorder?A generalist's guide to treating patients with depression with an emphasis on using side effects to tailor antidepressant therapy Design and synthesis of 4-heteroaryl 1,2,3,4-tetrahydroisoquinolines as triple reuptake inhibitors.Bupropion versus sertraline in the treatment of depressive patients with binge eating disorder: retrospective cohort study.The efficacy and tolerability of bupropion in the treatment of major depressive disorder.Bupropion diversion and misuse in the correctional facility.Formation of threohydrobupropion from bupropion is dependent on 11β-hydroxysteroid dehydrogenase 1.Identification and Structural Characterization of Three New Metabolites of Bupropion in Humans The use of bupropion SR in cigarette smoking cessation Organic cation transporter variation and response to smoking cessation therapies Bupropion for interferon-alpha-induced depression in patients with hepatitis C viral infection: an open-label study Effect of comedication of bupropion and other antidepressants on body mass index.Drug treatment of depression in the 2000s: An overview of achievements in the last 10 years and future possibilities.Convulsive liability of bupropion hydrochloride metabolites in Swiss albino mice Spotlight on bupropion in major depressive disorder.Biological basis for the co-morbidity between smoking and mood disorders.Role of depressive symptoms in explaining socioeconomic status disparities in dietary quality and central adiposity among US adults: a structural equation modeling approach Bupropion therapy during pregnancy: the drug and its major metabolites in umbilical cord plasma and amniotic fluid.Acute systemic infusion of bupropion decrease formalin induced pain behavior in rat.Evidence-based, pharmacological treatment guideline for depression in Korea, revised edition.What happens next?: a claims database study of second-line pharmacotherapy in patients with major depressive disorder (MDD) who initiate selective serotonin reuptake inhibitor (SSRI) treatment.Clinical relevance of fatigue as a residual symptom in major depressive disorder.Drug safety evaluation of naltrexone/bupropion for the treatment of obesity.Is Mania the Hypertension of the Mood? Discussion of A Hypothesis.(±)-2-(N-tert-Butylamino)-3'-[(125)I]-iodo-4'-azidopropiophenone: a dopamine transporter and nicotinic acetylcholine receptor photoaffinity ligand based on bupropion (Wellbutrin, Zyban).Two Cases of Refractory Cardiogenic Shock Secondary to Bupropion Successfully Treated with Veno-Arterial Extracorporeal Membrane Oxygenation.Bupropion-Induced Stuttering.Antidepressant and Antipsychotic Drugs.Identification of non-reported bupropion metabolites in human plasma.

P2860

Q24642937-A1ADA96E-99C5-4D09-8EB5-650080E9135F Q24644586-302E7D47-D48C-4344-AACF-6700C4C16E6F Q26747727-D55AAEBD-6AC6-477E-9270-4D1CB9F97C7C Q26773281-71AEAD9A-A186-448A-97B2-2DE8D3893624 Q27028050-C580C219-BDE1-4AD3-B010-FBB43D18C3E2 Q28300843-B784B995-3BD0-4945-AFD3-C9EB0C361ABD Q28535127-EBFF2752-1317-4252-8EE5-89000C6326AA Q30411445-B3BFED16-DC37-4C93-8C0B-4DE1A66FC874 Q30449347-4E430826-4A95-42AD-BA07-B223E53058F5 Q33582063-5F83B3F8-26B2-4DA7-967A-E51FBE5514A5 Q33811888-458DCA95-7160-4A65-9D88-5508DF331614 Q33869517-EB0358BD-80A7-4884-A64A-557F19C9DF7F Q33884174-8ADEFB62-C731-482D-93AD-78C43DB4F862 Q33889048-88DC4D83-8CEE-434E-84A6-7716B858E0F3 Q34217281-552630FC-F37B-45D6-8F3E-1B46445C09EB Q34226014-5D3B3896-7FD9-473F-AB87-64A141F30971 Q34352385-5F276BDC-CE3E-4568-AA5A-BB7295B06D8C Q34353804-B863AE36-A60C-4FB0-B3B9-D9DB7142FF79 Q34540994-6E1FE839-444E-4ED1-AF65-E15A8BF416CF Q34779470-AD535A6E-BB2E-4653-B62B-D4ECCD573A5A Q34974830-7F51FA07-F030-4A3C-8CD6-F8CB52359535 Q35028323-DCA5B7D8-95CB-44F1-8C95-62591627C7EC Q35852531-70B329A0-1E15-4887-9703-3E4B45B1D3E9 Q36637666-C4B36C07-2CEC-4E99-B0A4-1C88D60AAF3F Q36957093-EDE7AD26-85CE-41EE-8361-A776B2CF4C46 Q37189006-44446505-0A34-47BD-9CD0-98B0CDF79CFA Q37253537-963C4B6D-05D1-4383-973F-4C79BEF43282 Q37348390-B9CFE14E-AA5E-424F-A8E4-80AB8E79F716 Q37659046-D456691B-640F-4E78-A1DD-1BE1A3382269 Q37709123-4C741527-A5BE-428A-9F66-8198665CCEB2 Q37710333-AD0360E4-A2EE-4783-8418-98DC872E8FD4 Q37715559-4B61158B-3104-4EF4-86C1-241FC46E5E6D Q38151637-7CE603D2-3A83-42FC-A21F-19EC23BE4C95 Q38207128-C1586FEE-55C6-4558-8BD4-2730ADB67252 Q39305705-1DDA8925-2E25-4540-B073-076A207C1EDB Q40079534-1C5B8390-882D-487E-A9C7-496AEB8D93AC Q41240829-967372F7-1F04-4173-B3FA-E7C4D926A4A0 Q41818016-E4115312-8949-44D4-AE81-91193E4151FC Q42018725-4EAE852F-B952-4ED7-905C-0A11B50186D3 Q42360559-F1B8333F-66ED-4B16-8C74-E12AC853BF0E

P2860

15 years of clinical experience with bupropion HCl: from bupropion to bupropion SR to bupropion XL

http://www.wikidata.org/entity/Q24530904

description

2005 nî lūn-bûn

@nan

2005 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

15 years of clinical experienc ...... o bupropion SR to bupropion XL

@ast

15 years of clinical experienc ...... o bupropion SR to bupropion XL

@en

15 years of clinical experienc ...... o bupropion SR to bupropion XL

@en-gb

15 years of clinical experienc ...... o bupropion SR to bupropion XL

@nl

type

label

15 years of clinical experienc ...... o bupropion SR to bupropion XL

@ast

15 years of clinical experienc ...... o bupropion SR to bupropion XL

@en

15 years of clinical experienc ...... o bupropion SR to bupropion XL

@en-gb

15 years of clinical experienc ...... o bupropion SR to bupropion XL

@nl

prefLabel

15 years of clinical experienc ...... o bupropion SR to bupropion XL

@ast

15 years of clinical experienc ...... o bupropion SR to bupropion XL

@en

15 years of clinical experienc ...... o bupropion SR to bupropion XL

@en-gb

15 years of clinical experienc ...... o bupropion SR to bupropion XL

@nl

P1433

Q24530904-340351A7-1772-4725-B442-53633E136861

P1476

Q24530904-9D689DDE-6013-4654-8EA6-F522C93CCFEB

P2093

Q24530904-3D3CB495-2844-4B2D-89D6-12AA57132BA4

Q24530904-47569B86-F752-40CA-9CC5-C5A7A91ADCA4

Q24530904-48D24BB1-8417-4D7F-BB40-7DA60DDBF914

Q24530904-60B948C3-DF06-4CB9-BDF5-682E719FA685

Q24530904-CF8A2E00-6632-4B00-A051-64767E77114B

Q24530904-DF343366-F7D3-4B1C-AE8B-23B2F29E039F

P2860

Q24530904-05521244-A719-46F6-AA00-CD48231A5A1D

Q24530904-07458480-58A4-4021-ACA4-001F6EA056B0

Q24530904-0B187D14-CE14-4BF1-AC97-6F4176AD5109

Q24530904-14ACE85E-4F8F-4BDC-83A5-F6B5461667A8

Q24530904-17534395-F11C-407A-BCCC-C8F34D323D67

Q24530904-18A821F5-C9CB-471A-B930-8DA521A68934

Q24530904-190760A5-1E15-48C2-BA81-6A3D23328A23

Q24530904-1A66839F-11DF-449D-BE81-BF45C85BA6DF

Q24530904-1E3EFE63-942B-4F32-B8A1-55B127096765

Q24530904-1FECF9EC-6BD2-4797-83D9-A9D4A2D303F7

P304

Q24530904-9D2A625E-14D6-458E-98D6-1D686D26DDCE

P31

Q24530904-68514350-F6BA-4FCA-9F09-65CDEF57DC1C

P3181

Q24530904-DA789FEA-37DD-440F-A44B-1F95272ACB79

P356

Q24530904-5ADAD245-2B21-40C3-92E2-253C19B79C30

P407

Q24530904-6AB538E4-825A-4D17-9AFE-7476640CC60A

P433

Q24530904-D9155811-C14F-4E34-AA52-0740AABECD8E

P478

Q24530904-A366AD88-7126-4002-A88E-95D55ABE5A94

P50

Q24530904-73662E82-17F7-4F70-9283-7B96EA557BBF

Q24530904-C5650FDA-0258-4732-8717-12B209E958B9

P577

Q24530904-5CC3F0BD-6664-4FF9-908D-3A2BA9CC0C87

P698

Q24530904-BCF4E424-4D01-435B-ABE1-4128FF8032E7

P932

Q24530904-5C2B2B14-A727-48FF-B3F5-A209B80DE84C

P3181

P356

P1433

Primary Care Companion to the Journal of Clinical Psychiatry

P1476

15 years of clinical experienc ...... o bupropion SR to bupropion XL

@en

P2093

A John Rush

http://www.w3.org/2001/XMLSchema#string

J Andrew Johnston

http://www.w3.org/2001/XMLSchema#string

James F Pradko

http://www.w3.org/2001/XMLSchema#string

Maurizio Fava

http://www.w3.org/2001/XMLSchema#string

Michael E Thase

http://www.w3.org/2001/XMLSchema#string

Stephen M Stahl

http://www.w3.org/2001/XMLSchema#string

P2860

A Review of the Neuropharmacology of Bupropion, a Dual Norepinephrine and Dopamine Reuptake Inhibitor

A placebo-controlled comparison of the antidepressant efficacy and effects on sexual functioning of sustained-release bupropion and sertraline

Sexual dysfunction associated with the treatment of depression: a placebo-controlled comparison of bupropion sustained release and sertraline treatment

Substitution of an SSRI with bupropion sustained release following SSRI-induced sexual dysfunction.

Prevalence of sexual dysfunction among newer antidepressants.

A placebo-controlled trial of bupropion SR as an antidote for selective serotonin reuptake inhibitor-induced sexual dysfunction.

Efficacy and safety of bupropion SR for smoking cessation: data from clinical trials and five years of postmarketing experience.

Remission rates following antidepressant therapy with bupropion or selective serotonin reuptake inhibitors: a meta-analysis of original data from 7 randomized controlled trials.

A controlled clinical trial of bupropion for attention deficit hyperactivity disorder in adults.

Bupropion occupancy of the dopamine transporter is low during clinical treatment.

P304

106-113

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3069143

http://www.w3.org/2001/XMLSchema#string

P356

10.4088/PCC.V07N0305

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

P577

2005-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16027765

http://www.w3.org/2001/XMLSchema#string

P932

1163271

http://www.w3.org/2001/XMLSchema#string